|
|
|
Insider
Information: |
May Simon |
Relationship: |
Senior Vice President |
City: |
Hercules |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
7,340 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,583,311 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
7,340 |
|
|
Total
Value |
$1,583,311 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bio Rad Laboratories Inc |
BIO |
EVP, President, LSG |
2023-09-04 |
3,105 |
|
0 |
Premium* |
|
Agilent Technologies Inc |
A |
Senior Vice President |
2024-05-08 |
4,235 |
2024-05-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSGOfficer |
|
2022-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
43 |
|
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-01 |
4 |
D |
$486.25 |
$62,726 |
D/D |
(129) |
322 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
371 |
451 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-02 |
4 |
D |
$478.32 |
$67,921 |
D/D |
(142) |
589 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
409 |
731 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-03 |
4 |
D |
$478.32 |
$87,054 |
D/D |
(182) |
933 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
526 |
1,115 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-04 |
4 |
D |
$478.32 |
$136,321 |
D/D |
(285) |
1,248 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
600 |
1,533 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
600 |
1,848 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2022-09-05 |
4 |
D |
$478.32 |
$142,539 |
D/D |
(298) |
1,550 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-01 |
4 |
D |
$394.60 |
$121,931 |
D/D |
(309) |
2,189 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
891 |
2,318 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-02 |
4 |
D |
$394.60 |
$56,033 |
D/D |
(142) |
2,456 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
409 |
2,598 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
526 |
2,982 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-03 |
4 |
D |
$394.60 |
$71,817 |
D/D |
(182) |
2,800 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-04 |
4 |
D |
$394.60 |
$116,407 |
D/D |
(295) |
3,105 |
0 |
- |
|
BIO |
Bio Rad Laboratories Inc |
EVP, President, LSG |
|
2023-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
600 |
3,400 |
0 |
- |
|
A |
Agilent Technologies Inc |
Senior Vice President |
|
2024-05-08 |
4 |
A |
$142.80 |
$604,758 |
D/D |
4,235 |
4,235 |
0 |
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|